Procaps Group S.A. (NASDAQ:PROC) Short Interest Update

Procaps Group S.A. (NASDAQ:PROC) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 133,300 shares, a drop of 18.4% from the December 31st total of 163,300 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading volume of 98,600 shares, the days-to-cover ratio is presently 1.4 days.

Procaps Group Trading Up 3.9 %

PROC traded up $0.06 during trading on Thursday, reaching $1.58. The company’s stock had a trading volume of 58,842 shares, compared to its average volume of 23,355. Procaps Group has a 1 year low of $0.50 and a 1 year high of $4.15. The firm has a fifty day simple moving average of $1.98 and a two-hundred day simple moving average of $1.95.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.